BOLD vs DERM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BOLD Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while DERM counters with relative strength in Valuation. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DERM at 8.3x Forward P/E and -2.9% operating margin (+7.6% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DERM sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BOLD | DERM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $56.2M | $100.2M | Larger Scale | DERM |
| Trailing P/E Ratio Valuation | N/M | 17.6x | Lower Multiple | DERM |
| Forward P/E Ratio Valuation | N/M | 8.3x | Lower Multiple | DERM |
| Revenue Growth (YoY) Growth | +0.0% | +7.6% | Higher Growth | DERM |
| Operating Margin (TTM) Profitability | 0.0% | -2.9% | Higher Margin | BOLD |
| Net Profit Margin Profitability | 0.0% | -7.3% | Higher Margin | BOLD |
| Return on Equity (ROE) Capital Efficiency | -64.6% | -17.6% | Higher ROE | DERM |
| 52-Week Range Position Momentum | 62% ($1โ$3) | 1% ($3โ$10) | Stronger Trend | BOLD |
| Beta / 30D Volatility Risk Regime | -0.08ฮฒ ยท 28% Vol | 2.08ฮฒ ยท 77% Vol | Lower Realized Risk | BOLD |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 40.9 / 100 (SELL) | Higher Composite | DERM |